DANIEL J BOOSER to In Situ Hybridization, Fluorescence
This is a "connection" page, showing publications DANIEL J BOOSER has written about In Situ Hybridization, Fluorescence.
Connection Strength
0.028
-
Comparison of HER-2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma. Cancer. 2005 May 01; 103(9):1763-9.
Score: 0.011
-
Gene expression profiles obtained from fine-needle aspirations of breast cancer reliably identify routine prognostic markers and reveal large-scale molecular differences between estrogen-negative and estrogen-positive tumors. Clin Cancer Res. 2003 Jul; 9(7):2406-15.
Score: 0.009
-
Phase II study of weekly docetaxel and trastuzumab for patients with HER-2-overexpressing metastatic breast cancer. J Clin Oncol. 2002 Apr 01; 20(7):1800-8.
Score: 0.009